Literature DB >> 20675395

Buying 'legal' recreational drugs does not mean that you are not breaking the law.

J Ramsey1, P I Dargan, M Smyllie, S Davies, J Button, D W Holt, D M Wood.   

Abstract

BACKGROUND: Recreational drug use in the UK is common; sources of recreational drugs are changing, with increasing purchase of legal highs from the Internet. Previous studies have shown that there is not consistency of active ingredient(s) in legal highs purchased from the Internet. AIM: The aim of this study was to determine the impact of the 16 April 2010 change to the Misuse of Drugs Act (1971) on the content of 'legal highs' purchased over the Internet and supplied within the UK.
METHODS: Legal highs were purchased from a number of different Internet suppliers and the active ingredients determined by analysis undertaken within a Home Office approved and licensed laboratory set in a UK academic institution. The active ingredient(s) detected on screening were then compared to the UK legislation in force at the time of purchase to determine whether each individual 'legal' high was in fact legal or not.
RESULTS: All 18 products purchased prior to the change in the UK legislation contained active ingredients that were legal under the Misuse of Drugs Act (1971) in force at that time. Six products were purchased and analysed after the changes to the UK Misuse of Drugs Act (1971) on the 16 April 2010. Five of the products contained information, either on the Internet site or the packaging, stating that the product contained legal substances; the final product did not specify the active ingredient and so purchasers would be unable to determine if this was truly a legal product. Five of the six products contained an active ingredient that is a Class B drug under the Misuse of Drugs Act (1971); the other product contained an unlicensed medicine not controlled under the Misuse of Drugs Act (1971).
CONCLUSION: We have shown in this study that some drugs sold as 'legal' highs contain drugs that are controlled under the Misuse of Drugs Act (1971). Under current UK legislation, individuals purchasing legal highs that contained controlled drugs would be subject to the same penalties as if they had knowingly purchased a controlled drug. Dissemination of information on the harm associated with the use of legal highs should also inform individuals that they may be purchasing controlled substances and the potential legal consequences of this.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675395     DOI: 10.1093/qjmed/hcq132

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  13 in total

1.  Synthetic cathinones and their rewarding and reinforcing effects in rodents.

Authors:  Lucas R Watterson; M Foster Olive
Journal:  Adv Neurosci (Hindawi)       Date:  2014-06-04

2.  Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.

Authors:  David M Wood; Susannah Davies; Malgorzata Puchnarewicz; Atholl Johnston; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

3.  Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances).

Authors:  Susannah Davies; Terry Lee; John Ramsey; Paul I Dargan; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2011-10-29       Impact factor: 2.953

4.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

Review 5.  The toxicology of bath salts: a review of synthetic cathinones.

Authors:  Jane M Prosser; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2012-03

6.  A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity.

Authors:  David M Wood; Malgorzata Puchnarewicz; Atholl Johnston; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2011-10-29       Impact factor: 2.953

7.  Using internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4'-dimethylaminorex.

Authors:  Hisham Nizar; Paul I Dargan; David M Wood
Journal:  J Med Toxicol       Date:  2015-03

8.  Acute toxicity associated with analytically confirmed recreational use of methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane).

Authors:  Hwee Min D Lee; David M Wood; Simon Hudson; John R H Archer; Paul I Dargan
Journal:  J Med Toxicol       Date:  2014-09

Review 9.  Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

Authors:  Fabrizio Schifano; Antonio Albanese; Suzanne Fergus; Jackie L Stair; Paolo Deluca; Ornella Corazza; Zoe Davey; John Corkery; Holger Siemann; Norbert Scherbaum; Magi' Farre'; Marta Torrens; Zsolt Demetrovics; A Hamid Ghodse
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

10.  A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?

Authors:  Tammy C Ayres; John W Bond
Journal:  BMJ Open       Date:  2012-07-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.